Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers

BACKGROUND: The kinetics of neutralizing antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) play an important role in evaluating vaccine efficacy and durability, herd immunity, additional vaccination, and prediction models of immune protection against coronavirus disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sera, Lee, Yuil, Kim, Dong Wan, Park, Won Sang, Yoon, Jung Hwan, Lee, Jung Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987172/
https://www.ncbi.nlm.nih.gov/pubmed/35384425
http://dx.doi.org/10.3947/ic.2022.0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987172/
https://www.ncbi.nlm.nih.gov/pubmed/35384425
http://dx.doi.org/10.3947/ic.2022.0009

Ejemplares similares